Skip to main content
Samuel Denmeade, MD, Oncology, Baltimore, MD

SamuelRayDenmeadeMD

Oncology Baltimore, MD

Professor of Oncology, Professor of Urology, Johns Hopkins University School of Medicine

Dr. Denmeade is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Denmeade's full profile

Already have an account?

  • Office

    201 North Broadway Street
    Viragh BLDG 5th FL
    Baltimore, MD 21287
    Phone+1 410-955-8964
    Fax+1 410-367-2194

Summary

  • Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Director of the Genitourinary Oncology Program at Johns Hopkins in Baltimore, MD. He is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 28 years. He is experienced in treatment of advanced prostate cancer. He has more than 200 publications and developed the concept of Bipolar Androgen Therapy for metastatic prostate cancer

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1993 - 1996
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1989 - 1992
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1993 - 2026
  • VA State Medical License
    VA State Medical License 2024 - 2026
  • PA State Medical License
    PA State Medical License 1992 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Top Doctors:Baltimore Area Castle Connolly, 2012
  • Top Doctors:Washington-Baltimore Castle Connolly, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer  
    Emmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology

Press Mentions

  • Prostate Cancer Drug Is Found to Be an Effective Antiviral Against Coronavirus and the Common Cold
    Prostate Cancer Drug Is Found to Be an Effective Antiviral Against Coronavirus and the Common ColdFebruary 3rd, 2021
  • Health Tips: This Experimental Prostate Cancer Treatment Is Shrinking Tumors
    Health Tips: This Experimental Prostate Cancer Treatment Is Shrinking TumorsApril 29th, 2017
  • Health Tips This Experimental Prostate Cancer Treatment Is Shrinking Tumors
    Health Tips This Experimental Prostate Cancer Treatment Is Shrinking TumorsApril 28th, 2017
  • Join now to see all

Other Languages

  • Spanish